NATONI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 39
Totale 39
Nazione #
IT - Italia 39
Totale 39
Città #
Rome 39
Totale 39
Nome #
Inhibition of Sialylation Impairs Adhesion on Madcam-1 and E-Selectin and Sensitize Multiple Myeloma Cells to Bortezomib in a Xenograft Mouse Model, file 7fc3a881-9267-42c3-81ff-3c7103a3eee3 6
Multiple Myeloma Cells Express Functional E-Selectin Ligands Which Can be Inhibited Both in-Vitro and in-Vivo Leading to Prolongation of Survival in a Murine Transplant Model, file 61ba17f6-362e-4541-837b-394243b0803a 5
PHA767491, a Dual Cdc7/CDK9 Inhibitor, with Potential to Target Both Proliferation and Survival in CLL, file a001ec88-f39d-4353-bff6-cd242da08340 5
E-Selectin Ligand Expression Increases with Progression of Myeloma and Induces Drug Resistance in a Murine Transplant Model, Which Is Overcome By the Glycomimetic E-Selectin Antagonist, GMI-1271, file 45e9df29-9efe-4d04-94bb-10aaa3e4f9d8 3
P861: SIALOFUCOSYLATED STRUCTURES ENABLE PLATELET BINDING TO MYELOMA CELLS CONFERRING PROTECTION FROM NK-MEDIATED CYTOTOXICITY, file b6334a76-0bd1-4357-9a2c-c733bf1da86b 3
Dual Cdc7/Cdk9 kinase inhibitor, PHA-767491, targets both quiescent and proliferating CLL cells, file 73484529-f345-44d2-a3ad-1fcf72a7a767 2
Targeting Siglec-7: A Novel Immunotherapeutic Approach to Potentiate the Cytotoxic Functions of Natural Killer Cells Against Multiple Myeloma, file e6c7b6bc-cf2f-45bb-94b1-ed43db8d039f 2
CD38(low) Natural Killer Cells Transiently Expressing CD16(F158V) m-RNA Potentiates the Therapeutic Activity of Daratumumab Against Multiple Myeloma with Minimal Effector NK Cell Fratricide, file 0e669431-fdb7-48fa-99a1-3e8baed590a8 1
Targeting siglec-7: a novel immunotherapeutic approach to potentiate the cytotoxic functions of natural killer cells against multiple myeloma, file 2095fa52-818a-403f-aa61-fc848a055e82 1
A cell culture system that mimics chronic lymphocytic leukemia cells microenvironment for drug screening and characterization, file 2267a237-c602-49a3-bc18-3e992d0302a9 1
Cybord-Dara in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Follow up Results from the 16Bcni-001/Ctrial-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment, file 387eb9ab-3061-4753-920c-ef969c77e32c 1
Hypersialylation protects Myeloma cells from NK cell mediated killing and this can be overcome by targeted desialylation using a sialyltransferase inhibitor, file 454d81c8-ce21-4258-8065-773c5d94ccf6 1
iCARE-2 fellowship, file 5d3b2958-9bf5-4f52-8d9c-1a073668a460 1
Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model, file 759a5371-a779-4e6d-8cee-4ed9dc4022bf 1
Hypersialylation Protects Multiple Myeloma Cells from NK Cell-Mediated Immunosurveillance and This Can be Overcome By Targeted Desialylation Using a Sialyltransferase Inhibitor, file 83a425bd-b39c-4bcd-b522-3e136d91f9eb 1
A 13-Glycosylation Gene Signature in Multiple Myeloma Can Predicts Survival and Identifies Candidates for Targeted Therapy (GiMM13), file 85bcb98e-55ed-4166-9fa8-d8e11e4082d9 1
Platelets Preferentially Bind to Myeloma Cells Bearing Sialofucosylated Structures and Protect Them from Natural Killar Cell-Mediated Cytotoxicity, file 9f184488-de78-46e4-ad68-3a7a2c16e7ea 1
Potentiation of Anti-Myeloma Activity of Daratumumab with Combination of Cyclophosphamide, Lenalidomide or Bortezomib Via a Tumor Secretory Response That Greatly Augments Macrophage-Induced ADCP, file a4438155-7c01-44e1-b9b5-7276d6ab8e88 1
Silencing The Sialyltransferase Gene ST3GAL6 Inhibits Adhesion and Migration Of Myeloma Cells In Vitro and Reduces The Homing and Proliferation Of Tumor Cells In Vivo, file b539f2bb-1ee0-41ec-bb66-80675ff77030 1
Treatment of proliferative disorders with a death receptor agonist, file f23bc4ab-a611-4bd7-b71b-c92c1220fc6e 1
Totale 39
Categoria #
all - tutte 40
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1
selected - selezionate 0
volume - volumi 0
Totale 41


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202339 0 0 0 0 0 0 0 0 22 0 0 17
Totale 39